Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 20 |
NetGPI | no | yes: 0, no: 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0016281 | eukaryotic translation initiation factor 4F complex | 2 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7WZL5
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 21 |
GO:0003723 | RNA binding | 4 | 21 |
GO:0003743 | translation initiation factor activity | 4 | 21 |
GO:0005488 | binding | 1 | 21 |
GO:0008135 | translation factor activity, RNA binding | 3 | 21 |
GO:0045182 | translation regulator activity | 1 | 21 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 21 |
GO:0097159 | organic cyclic compound binding | 2 | 21 |
GO:1901363 | heterocyclic compound binding | 2 | 21 |
GO:0000339 | RNA cap binding | 5 | 2 |
GO:0000340 | RNA 7-methylguanosine cap binding | 6 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.287 |
DEG_APCC_DBOX_1 | 101 | 109 | PF00400 | 0.549 |
DOC_MAPK_MEF2A_6 | 142 | 149 | PF00069 | 0.510 |
DOC_PP2B_PxIxI_1 | 171 | 177 | PF00149 | 0.446 |
DOC_PP4_FxxP_1 | 26 | 29 | PF00568 | 0.559 |
DOC_SPAK_OSR1_1 | 90 | 94 | PF12202 | 0.559 |
DOC_WW_Pin1_4 | 151 | 156 | PF00397 | 0.557 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.723 |
LIG_deltaCOP1_diTrp_1 | 21 | 26 | PF00928 | 0.530 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.491 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.555 |
LIG_FHA_2 | 46 | 52 | PF00498 | 0.485 |
LIG_LIR_Gen_1 | 50 | 61 | PF02991 | 0.486 |
LIG_LIR_Gen_1 | 79 | 89 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 21 | 27 | PF02991 | 0.499 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 79 | 85 | PF02991 | 0.473 |
LIG_Pex14_1 | 23 | 27 | PF04695 | 0.491 |
LIG_SH2_CRK | 53 | 57 | PF00017 | 0.530 |
LIG_SH2_NCK_1 | 53 | 57 | PF00017 | 0.530 |
LIG_SH2_SRC | 27 | 30 | PF00017 | 0.530 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.554 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.441 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.477 |
LIG_SH3_2 | 15 | 20 | PF14604 | 0.542 |
LIG_SH3_3 | 12 | 18 | PF00018 | 0.557 |
LIG_TRAF2_1 | 48 | 51 | PF00917 | 0.456 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.551 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.515 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.478 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.642 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.332 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.355 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.476 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.705 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.517 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.499 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.551 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.493 |
MOD_NEK2_2 | 141 | 146 | PF00069 | 0.559 |
MOD_PIKK_1 | 96 | 102 | PF00454 | 0.541 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.491 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.499 |
MOD_ProDKin_1 | 151 | 157 | PF00069 | 0.557 |
MOD_SUMO_rev_2 | 35 | 43 | PF00179 | 0.535 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.516 |
TRG_NES_CRM1_1 | 103 | 115 | PF08389 | 0.559 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5E4 | Leptomonas seymouri | 74% | 100% |
A0A0N1ILF7 | Leptomonas seymouri | 34% | 96% |
A0A0S4IN32 | Bodo saltans | 38% | 99% |
A0A0S4IZ31 | Bodo saltans | 34% | 100% |
A0A1X0NSI0 | Trypanosomatidae | 44% | 98% |
A0A1X0P9L6 | Trypanosomatidae | 35% | 87% |
A0A3S7XAF1 | Leishmania donovani | 33% | 85% |
A0A422P286 | Trypanosoma rangeli | 32% | 91% |
A4HEN3 | Leishmania braziliensis | 93% | 100% |
A4HNR9 | Leishmania braziliensis | 32% | 100% |
A4I1W1 | Leishmania infantum | 99% | 100% |
A4ICS5 | Leishmania infantum | 33% | 100% |
C9ZS59 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 98% |
D0A2M9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 93% |
E9ASH9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9AY06 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q4Q217 | Leishmania major | 33% | 100% |
Q4Q9G7 | Leishmania major | 97% | 100% |
V5BZH5 | Trypanosoma cruzi | 48% | 98% |